GCOR Genencor International, (MM)

Genencor International, Inc. to Present at the UBS Global Life Sciences Conference PALO ALTO, Calif., Sept. 20 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) today announced that the company will present at the UBS Global Life Sciences Conference at 9:00 a.m. EDT on Thursday, September 30th, 2004 at The Grand Hyatt in New York, NY. Jean- Jacques Bienaime, chairman, chief executive officer and president of Genencor International, Inc. will provide an overview of the company. The live audio webcast of the presentation as well as a replay will be available at http://www.ibb.ubs.com/ and the slide presentation may be accessed on the homepage at http://www.genencor.com/ for a period of 30 days following the conference. About Genencor Genencor International, Inc. (http://www.genencor.com/) is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to improve the quality of life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. DATASOURCE: Genencor International, Inc. CONTACT: media, Valerie Tucker, +1-650-846-7571, or investors, Thomas Rathjen, +1-650-846-7500, both of Genencor International, Inc. Web site: http://www.genencor.com/

Copyright